Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimens for pediatric acute leukemia.
Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J, Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K. Kato M, et al. Among authors: sakamaki h. Biol Blood Marrow Transplant. 2013 Dec;19(12):1690-4. doi: 10.1016/j.bbmt.2013.09.012. Epub 2013 Sep 23. Biol Blood Marrow Transplant. 2013. PMID: 24071595 Free article.
Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation.
Sakamaki H, Yuasa K, Goto H, Tanikawa S, Akiyama H, Onozawa Y, Okamoto R, Maeda Y, Sasaki T, Kaku H, Tsuzuki S, Takamoto S, Mochida Y, Minematsu T, Minamishima Y. Sakamaki H, et al. Bone Marrow Transplant. 1997 Jul;20(2):143-7. doi: 10.1038/sj.bmt.1700856. Bone Marrow Transplant. 1997. PMID: 9244418 Clinical Trial.
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F. Kodera Y, et al. Among authors: sakamaki h. Bone Marrow Transplant. 1999 Nov;24(9):995-1003. doi: 10.1038/sj.bmt.1702027. Bone Marrow Transplant. 1999. PMID: 10556959
Second allogeneic peripheral blood stem cell transplantation with fludarabine-based low-intensity conditioning regimen for relapsed myelodysplastic syndrome after allogeneic bone marrow transplantation.
Kono N, Ohashi K, Sasaki E, Okoshi Y, Mizuchi D, Mori S, Akiyama H, Karasawa K, Kaku H, Okamoto R, Maeda Y, Sasaki T, Okuyama Y, Hiruma K, Sakamaki H. Kono N, et al. Among authors: sakamaki h. Int J Hematol. 2001 Jan;73(1):122-5. doi: 10.1007/BF02981914. Int J Hematol. 2001. PMID: 11372748
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, Kawa K, Hamajima N, Asano S, Kodera Y. Morishima Y, et al. Among authors: sakamaki h. Blood. 2002 Jun 1;99(11):4200-6. doi: 10.1182/blood.v99.11.4200. Blood. 2002. PMID: 12010826 Free article.
500 results